ArticlePediatric blood & cancer2013

Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas.

AeRang Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.